Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2335 |
Ebastine
Ebastel,依巴斯汀,LAS-W 090,Ebastin,Kestine,RP64305 |
Histamine Receptor | GPCR/G Protein; Immunology/Inflammation; Neuroscience |
Ebastine (Kestine) 是一种可口服的组胺 H1 受体拮抗剂,用于过敏性鼻炎的症状和慢性特发性荨麻疹的研究。 | |||
T10680 |
Carebastine
|
Histamine Receptor | GPCR/G Protein; Immunology/Inflammation; Neuroscience |
Carebastine 是 Ebastine 的活性代谢产物,可抑制巨噬细胞移动抑制因子的表达。它是组胺 H1 受体拮抗剂,可抑制 VEGF 诱导的 HUVEC 和 HPAEC 增殖,迁移和血管生成。 | |||
T2640 |
Rebastinib
DCC2036,DCC 2036,DCC-2036 |
Apoptosis; FLT; Bcr-Abl; Src | Angiogenesis; Apoptosis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors |
Rebastinib (DCC-2036) 是一种口服有效的,非 ATP 竞争性的 Bcr-Abl 抑制剂,作用于 Abl1WT 和 Abl1T315I,IC50分别为 0.8 nM 和 4 nM,还抑制 LYN、SRC、HCK、FGR、FLT3、KDR 和 Tie-2,对 c-Kit 的活性低。Rebastinib 对 Angiopoietin2-Tie2通路具有抑制作用。 | |||
T37515 |
Hydroxy Ebastine
|
||
Hydroxy Ebastine is an ebastine metabolite. Ebastine undergoes rapid first-pass metabolism by the cytochrome P450 isoform CYP2J2 to form hydroxy ebastine which is then metabolized by CYP2J2 and CYP3A4 to form carebastine. |